Sanofi Joins AI Gold Rush in €4.6B Drug Discovery Pact with Exscientia
As big pharma companies flock to drug discovery collaborations with artificial intelligence (AI) firms, the…
As big pharma companies flock to drug discovery collaborations with artificial intelligence (AI) firms, the…
Exscientia’s lucrative entry onto the Nasdaq last week demonstrated investors are still excited by efforts…
Scotland has a thriving life sciences ecosystem with strengths in oncology, genetic engineering, and industrial…
With the global Covid-19 outbreak in early 2020, pharma companies and biotechs have increasingly turned…
As we enter 2021, the biotech industry is already bustling with activity. Here’s a list…
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
The UK company Exscientia will use its AI-driven drug discovery platform to examine a collection…
A drug designed by the UK firm Exscientia using AI-powered software has entered into a…
In a deal with €22M paid upfront and undisclosed “substantial milestones and royalties,” Exscientia will…
Oxford-based Exscientia has closed a €23M ($26M) Series B round and announced a partnership with…
Tis the season for Glühwein, Tannenbäume, and lights in Berlin, and Labiotech is celebrating with…
After Sanofi recruited Exscientia in a €250M deal last May, GSK has taken an interest in…